logo

SANG

Sangoma Technologies·NASDAQ
--
--(--)
--
--(--)

SANG fundamentals

Sangoma Technologies (SANG) released its earnings on Feb 4, 2026: revenue was 51.50M (YoY -12.88%), beat estimates; EPS was -0.06 (YoY 0.00%), missed estimates.
Revenue / YoY
51.50M
-12.88%
EPS / YoY
-0.06
0.00%
Report date
Feb 4, 2026
SANG Earnings Call Summary for Q2,2026
  • Record MRR Growth: 67% Q/Q and 60% Y/Y MRR bookings driven by multi-site deals, signaling strategic shift to higher-value mid-market opportunities.
  • Cash Flow Strength: $8 million free cash flow and 122% EBITDA-to-cash conversion, enabling $5.2 million debt reduction.
  • Churn Improvement: Sub-1% churn rate reflects stable recurring revenue and superior customer experience.
  • Strategic Expansion: Wholesale channel wins (healthcare, carrier) and Prem UC hardware growth diversify revenue streams.
  • M&A Opportunity: Industry valuations down, creating potential for accretive acquisitions in targeted verticals.
EPS
Q2,2022
Q3,2022
Q4,2022
Q1,2023
Q2,2023
Q3,2023
Q4,2023
Q1,2024
Q2,2024
Q3,2024
Q4,2024
Q1,2025
Q2,2025
Q3,2025
Q4,2025
Q1,2026
Q2,2026
Actual
-0.078-0.212-2.987-0.06-0.084-0.02-0.72-0.07-0.1-0.04-0.05-0.06-0.06-0.040.01-0.07-0.06
Forecast
-0.04-0.0067-0.0886-0.1143-0.0543-0.0861-0.032-0.056-0.075-0.04-0.028-0.06-0.0225-0.0333-0.002-0.056-0.036
Surprise
-95.00%
-3064.18%
-3271.33%
+47.51%
-54.70%
+76.77%
-2150.00%
-25.00%
-33.33%
0.00%
-78.57%
0.00%
-166.67%
-20.12%
+600.00%
-25.00%
-66.67%
Revenue
Q2,2022
Q3,2022
Q4,2022
Q1,2023
Q2,2023
Q3,2023
Q4,2023
Q1,2024
Q2,2024
Q3,2024
Q4,2024
Q1,2025
Q2,2025
Q3,2025
Q4,2025
Q1,2026
Q2,2026
Actual
54.24M55.13M62.50M64.05M62.04M62.76M63.68M63.03M62.28M61.05M60.93M60.15M59.11M58.10M59.40M50.80M51.50M
Forecast
51.62M54.01M68.70M66.57M66.02M62.20M62.90M63.67M61.62M61.16M61.10M61.44M63.04M58.92M58.58M50.55M51.14M
Surprise
+5.07%
+2.07%
-9.02%
-3.79%
-6.03%
+0.91%
+1.24%
-1.00%
+1.07%
-0.19%
-0.28%
-2.09%
-6.23%
-1.39%
+1.40%
+0.50%
+0.71%

Earnings Call